Nitroimidazole drugs vary in their mode of action in the human parasite Giardia lamblia

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 2, Issue , 2012, Pages 166-170

  Leitsch, David ^a   Schlosser, Sarah ^a   Burgess, Anita ^b   Duchêne, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Nitroimidazoles; Protein binding; Thiol depletion; Translation elongation factor 1

Indexed keywords

2 NITROIMIDAZOLE; ELONGATION FACTOR; METRONIDAZOLE; RONIDAZOLE; THIOREDOXIN REDUCTASE; TINIDAZOLE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG PROTEIN BINDING; ENTAMOEBA HISTOLYTICA; GIARDIA LAMBLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; TRICHOMONAS VAGINALIS;

EID: 84861465108     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2012.04.002     Document Type: Article

References (25)

1. Bagchi S., Oniku A.E., Topping K., Mamhoud Z.N., Paget T.A. Programmed cell death in Giardia. Parasitology 2012, 12:1-10.
2. Boreham P.F., Phillips R.E., Shepherd R.W. A comparison of the in-vitro activity of some 5-nitroimidazoles and other compounds against Giardia intestinalis. J. Antimicrob. Chemother. 1985, 16:589-595.
3. Buret A.G. Pathophysiology of enteric infections with Giardia duodenalis. Parasite 2008, 15:261-265.
4. Campanati L., Monteiro-Real L.H. The effects of the antiprotozoal drugs metronidazole and furazolidone on trophozoites of Giardia lamblia (P1 strain). Parasitol. Res. 2002, 88:80-85.
5. Edwards D.I. Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 1993, 31:9-20.
6. Fung H.B., Doan T.L. Tinidazole: a nitroimidazole antiprotozoal agent. Clin. Ther. 2005, 27:1859-1884.
7. Ghosh E., Ghosh A., Ghosh A.N., Nozaki T., Ganguly S. Oxidative stress-induced cell cycle blockage and a protease-independent programmed cell death in microaerophilic Giardia lamblia. Drug Des. Dev. Ther. 2009, 3:103-110.
8. Keister D.B. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans. R. Soc. Trop. Med. Hyg. 1983, 77:487-488.
9. LaRusso N.F., Tomasz M., Kaplan D., Müller M. Absence of strand breaks in deoxyribonucleic acid treated with metronidazole. Antimicrob. Agents Chemother. 1978, 13:19-24.
10. Leitsch D., Radauer C., Paschinger K., Wilson I.B.H., Breiteneder H., Scheiner O., Duchêne M. Entamoeba histolytica: analysis of the trophozoite proteome by two-dimensional polyacrylamide gel electrophoresis. Exp. Parasitol. 2005, 110:191-195.
11. Leitsch D., Kolarich D., Wilson I.B.H., Altmann F., Duchêne M. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase. PLoS Biol. 2007, 5:e211.
12. Leitsch D., Kolarich D., Binder M., Stadlmann J., Altmann F., Duchêne Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance. Mol. Microbiol. 2009, 72:518-536.
13. Leitsch D., Burgess A.G., Dunn L.A., Krauer K.G., Tan K., Duchêne M., Upcroft P., Eckmann L., Upcroft J.A. Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. J. Antimicrob. Chemother. 2011, 66:1756-1766.
14. Mastronicola D., Giuffrè A., Testa F., Mura A., Forte E., Bordi E., Pucillo L.P., Fiori P.L., Sarti P. Giardia intestinalis escapes oxidative stress by colonizing the small intestine: a molecular hypothesis. IUBMB Life 2011, 63:21-25.
15. Moreno S.N.J., Docampo R. Mechanism of toxicity of nitro compounds used in chemotherapy of trichomoniasis. Environ. Health Perspect. 1985, 64:199-208.
16. Müller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 1983, 93:165-171.
17. Müller J., Rühle G., Müller N., Rossignol J.F., Hemphill A. In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells. Antimicrob. Agents Chemother. 2006, 50:162-170.
18. Nillius N., Müller J., Müller N. Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. J. Antimicrob. Chemother. 2011, 66:1029-1035.
19. Oxberry M.E., Thompson R.C., Reynoldson J.A. Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis and Spironucleus muris using transmission electron microscopy. Int. J. Parasitol. 1994, 24:695-703.
20. Pervez-Reyes E., Kalyanaraman B., Mason R.P. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes. Mol. Pharmacol. 1980, 17:239-244.
21. Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob. Agents Chemother. 1999, 43:1533-1541.
22. Tejman-Yarden N., Eckman L. New approaches to the treatment of giardiasis. Curr. Opin. Infect. Dis. 2011, 24:451-456.
23. Townson S.M., Upcroft J.A., Upcroft P. Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. Mol. Biochem. Parasitol. 1996, 79:183-193.
24. West S.B., Wislocki P.G., Fiorentini K.M., Alvaro R., Wolf F.J., Lu A.Y.H. Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation. Chem. Biol. Interact. 1982, 41:265-279.
25. Wislocki P.G., Bagan E.S., Vandenheuvel W.J.A., Walker R.A., Alvaro R.F., Arison B.H., Lu Y.H., Wolf F.J. Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteine. Chem. Biol. Interact. 1984, 49:13-25.